Stem cell intra-articular injection benefits are studied mainly in joint conditions involving cartilage wear and persistent inflammation. Research suggests locally delivered cells may influence the joint environment, though reported outcomes differ considerably between studies. Sample sizes, disease stage, and follow-up periods vary enough that direct comparison is difficult.
Because of that variation, general statements are less useful than condition-specific ones. Ask which studies relate to your joint, your stage, and your age group. Ask also what outcome measure was used, since improvements in reported comfort and changes visible on imaging are not the same thing.
Realistic framing includes the possibility of no change. Ask what would count as a meaningful result in your case, when it would be assessed, and what the plan would be if nothing shifts. Providers willing to define these points in advance are easier to hold to a clear standard afterward. Ask also how long after injection any assessment would take place, since change in joint conditions is generally evaluated over months rather than weeks.
